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Abstract
The Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) family plays a central role in antigenic variation and
cytoadhesion of P. falciparum infected erythrocytes. PfEMP1 proteins/var genes are classified into three main subfamilies
(UpsA, UpsB, and UpsC) that are hypothesized to have different roles in binding and disease. To investigate whether these
subfamilies have diverged in binding specificity and test if binding could be predicted by adhesion domain classification, we
generated a panel of 19 parasite lines that primarily expressed a single dominant var transcript and assayed binding against
12 known host receptors. By limited dilution cloning, only UpsB and UpsC var genes were isolated, indicating that UpsA var
gene expression is rare under in vitro culture conditions. Consequently, three UpsA variants were obtained by rosette
purification and selection with specific monoclonal antibodies to create a more representative panel. Binding assays
showed that CD36 was the most common adhesion partner of the parasite panel, followed by ICAM-1 and TSP-1, and that
CD36 and ICAM-1 binding variants were highly predicted by adhesion domain sequence classification. Binding to other host
receptors, including CSA, VCAM-1, HABP1, CD31/PECAM, E-selectin, Endoglin, CHO receptor ‘‘X’’, and Fractalkine, was rare or
absent. Our findings identify a category of larger PfEMP1 proteins that are under dual selection for ICAM-1 and CD36
binding. They also support that the UpsA group, in contrast to UpsB and UpsC var genes, has diverged from binding to the
major microvasculature receptor CD36 and likely uses other mechanisms to sequester in the microvasculature. These results
demonstrate that CD36 and ICAM-1 have left strong signatures of selection on the PfEMP1 family that can be detected by
adhesion domain sequence classification and have implications for how this family of proteins is specializing to exploit hosts
with varying levels of anti-malaria immunity.
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Introduction
Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1)
is a clonally variant adhesion protein that mediates binding of
infected erythrocytes (IE) to blood microvasculature and other host
cells [1]. Adherence of IEs to microvascular endothelium is a
major virulence factor and, in conjunction with the related
phenomenon of rosetting with uninfected erythrocytes, prevents
parasitized erythrocyte circulation to the spleen where parasites
may be destroyed [2]. Each parasite strain encodes ,60 PfEMP1
proteins, or var genes, which are expressed in a mutually exclusive
fashion [3,4]. Switches in var gene expression enable infected
erythrocytes to evade host immunity and may modify disease
manifestations by changing parasite binding tropism [5–7].
Efforts to unravel the role of PfEMP1 proteins in disease are
complicated by the vast diversity of var genes. Each parasite has a
diverse repertoire of genes, and there is limited overlap of
repertoires between parasite genomes [8–10]. However, genes can
be classified into three main subfamilies denoted Groups A, B, and
C [11], plus three unusual strain-transcendent variants (var1csa,
var2csa, and type 3 var) [12–15]. The var gene subfamilies possess
distinctive upstream flanking regions termed UpsA, UpsB, and
UpsC and are found in characteristic locations in the subtelomeric
or central regions of chromosomes [4,9,11,12]. It has been
hypothesized that var gene organization may contribute to a gene
recombination hierarchy that influences gene function and
evolution [1].
A number of studies have sought to correlate specific parasite
adhesion traits with disease outcome [16–19]. To date, at least 12
host receptors have been reported to mediate P. falciparum IE
binding [20]. CD36 binding is the most common adhesion trait in
the parasite population, followed by intercellular adhesion
molecule 1 (ICAM-1) [17,19]. These two receptors can synergize
under flow conditions to mediate infected erythrocyte binding to
microvasculature endothelium [21–23]. Most other binding
properties appear to be rarer or have not been studied in more
than one or a few parasite isolates. ICAM-1 binding has been
associated with cerebral malaria in some studies [17,24], but not in
others [19,25]. In addition, infected erythrocyte rosetting, or
binding of parasitized red blood cells to uninfected red blood cells,
has been associated with disease severity in African children
[26–28]. The clearest disease association is placental malaria, in
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VAR2CSA PfEMP1 protein and adhere to chondroitin sulfate A
(CSA) in the placenta [14,29]. VAR2CSA is a leading candidate
for a pregnancy malaria vaccine and a paradigm for syndrome-
specific anti-disease vaccine efforts.
Although the molecular basis for other adhesion-based
complications of P. falciparum is less established than for pregnancy
malaria, several observations suggest the antigenic diversity of
severe malaria isolates may also be limited. For instance, immunity
to severe malaria appears to be acquired after relatively few
infections [30,31]. In addition, isolates from severe malaria cases
appear to express a relatively restricted variant antigen surface
repertoire [32–34]. Furthermore, seroepidemiological and var
transcriptional profiling studies suggest that UpsA variants are
more commonly expressed in young African children with limited
immunity and in severe malaria infections [35–39]. Therefore it is
possible the UpsA group has become specialized to exploit
individuals with limited anti-malaria immunity, and it is important
to understand what may account for this expression profile.
To gain insight into PfEMP1 binding properties, sequence
classification has been performed [40]. The extracellular binding
region of PfEMP1 proteins is comprised of 2–7 receptor-like
domains called Duffy Binding-Like (DBL) and Cysteine Rich
Interdomain Region (CIDR) [41,42]. DBL and CIDR domains
are classified into different major types (a to e) and sub-types by
sequence criteria [10,40]. PfEMP1 proteins can be further
subdivided by protein architecture into small proteins with a
four-domain extracellular binding region (DBL-CIDR-DBL-
CIDR) and large proteins with a more complex domain
composition [43]. By comparison to other groups, nearly all of
the UpsA proteins are in the large protein category [9,10]. The
best characterized binding interactions are between CIDR::CD36
and DBLb::ICAM-1 [44–46]. In a repertoire-wide binding
comparison with CIDR recombinant proteins, the majority of
proteins encoded CD36 binding function, except for the UpsA
group, which had different CIDR sequence types than the UpsB
and UpsC groups [11,12,46]. UpsA proteins may also be under
less selection to bind ICAM-1, as 7 of 23 DBLb domains from the
IT4 parasite strain bound ICAM-1, but none of the 9 DBLb
domains tested from the UpsA group were ICAM-1 binders [44].
However, using a different binding analysis in a BioPlex system,
only a single DBLb recombinant protein from the 3D7 parasite
strain bound ICAM-1, and it was from an UpsA protein [45].
UpsA proteins have also been reported to bind ICAM-1
(PFD1235w) and PECAM-1 (PF11_0008) [47]. Taken together,
sequence and binding analysis suggest the UpsA group forms a
preferential gene recombination group that is under less selection
to bind the primary microvasculature receptor CD36. Further-
more, it is possible UpsA genes may have evolved specialized
binding properties that contribute to their preferential expression
in the malaria non-immune.
While sequence and binding analysis of isolated domains have
provided significant insights into PfEMP1 function, few binding
predictions have been confirmed for native proteins at the IE
surface, and it is not yet established whether binding differences
truly exist between var gene subfamilies. Furthermore, it is possible
that recombinant protein binding properties may be modified by
adjacent domains [48] or may not extrapolate to the native
PfEMP1 molecule [49]. Thus, there remain significant uncertain-
ties in our ability to predict IE binding, and there is still limited
understanding of how host selection is shaping the PfEMP1
variant antigen repertoire for parasite survival and transmission.
For this study, we generated a large panel of cloned parasite lines
from the cytoadhesive IT4/FCR3 parasite strain and selected
three highly enriched UpsA parasite lines with specific monoclonal
antibodies. This panel was employed to both investigate the major
host selection binding pressures operating on the protein family
and to evaluate binding predictions based on sequence informa-
tion and isolated domain binding assays.
Results
Generation of a panel of cloned parasite lines from a
cytoadhesive parasite line
To create a panel of parasites for phenotypic analysis, parasites
were cloned from a long-term, continuous culture of the IT4/25/5
clone A4 (Figure 1) [6]. The IT4/25/5 (IT4) parasite genotype is
unusual because the parasite maintained its cytoadhesion
capabilities after in vitro adaptation [50,51], making it a primary
model for this virulence determinant. A set of 54 var genes has
been reported from the IT4 parasite genotype [9,10]. The A4
cloned parasite line expresses a var gene (A4var/IT4var14) that has
an unusually high switch frequency (,1–2% per generation)
[6,52], resulting in PfEMP1 heterogeneity at the population level
in the long term culture. After 70 parasite divisions in continuous
culture, the long-term A4 culture had completely switched away
from the A4var gene (IT4var14) and expressed a mixture of
different var genes at low levels with IT4var26, IT4var31, and
IT4var37 predominating (Figure 2). Both IT4var31 (previously
referred to as C18var) and IT4var37 (previously referred to as
AFBR6) were also found to be common switch events in two
previous studies of var gene switching within the A4 parasite
lineage [7,52], suggesting that these particular genes may have
high ‘‘on’’ rates in unselected cultures.
Initially, 17 subclones were isolated from the long-term A4
parasite culture by limited dilution cloning (Figure 1). From var
transcription profiling, 6 of the subclones transcribed IT4var31 as
either the primary or secondary var transcript, 8 transcribed
dominant var gene transcripts distinct from each other, and a
dominant var transcript (present at greater than 50% of the total
var transcripts) could not be identified in 3 of the subclones by
qRT-PCR analysis (Table 1, and data not shown). Ten subclones
Author Summary
The malaria parasite Plasmodium falciparum persists in the
human host partly by avoiding elimination in the spleen
during blood stage infection. This strategy depends
principally upon members of the large and diverse PfEMP1
family of proteins that are exported to the surface of
infected erythrocytes. PfEMP1 proteins are important
targets for host protective antibody responses and encode
binding to several different host receptor proteins.
Switches in PfEMP1 expression allow parasites to evade
host antibodies and may precipitate severe disease when
infected erythrocytes accumulate in brain or placenta.
Consequently, the severity of malaria infection may
depend on the type of PfEMP1 protein expressed. In this
study, we employ a representative panel of distinct
PfEMP1 types and host receptor proteins to demonstrate
that CD36 and ICAM-1 binding properties of full-length
PfEMP1 are highly predicted by their domain composition.
We also find that CD36 binding is under strong selection in
many PfEMP1 proteins, but that a group of PfEMP1s
associated with more severe infections does not bind
CD36 and may utilize alternative means to sequester
infected erythrocytes. These findings have implications for
understanding the molecular basis for severe malaria.
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two that expressed IT4var31, were selected for phenotypic analysis
(Figure 3).
Of interest, there was negligible UpsA transcription in the long-
term A4 culture (Figure 2), and none of the isolated subclones
expressed an UpsA var gene (Figure 3). To attempt to enrich for
UpsA variants, the long-term A4 culture was panned on CD36
receptor protein and non-adherent parasites were selected.
Although the var transcriptional profile was modified after CD36
negative selection, this approach did not enrich for UpsA variants.
Instead, the frequent switch variant IT4var31 was the resulting
major transcript (data not shown). This again indicates that UpsA
genes are rare switch events in long-term A4 cultures.
To create a more representative panel for phenotypic analysis,
six previously isolated parasite lines from the IT4/FCR3 strain
and three UpsA parasite lines from different parasite strains (IT4/
FCR3, Palo Alto 89F5, and 3D7) (Figure 1) were included in the
binding studies. The three UpsA parasite lines (R29, VarO, and
Pf13) were isolated by rosette enrichment and selected for high
purity using specific monoclonal antibodies to the respective
PfEMP1 proteins [53]. Altogether, 19 parasite lines were
examined representing all three major var gene groups. Three of
the parasites in the panel expressed an UpsA protein as the
dominant var transcript, ten expressed an UpsB var gene, three
expressed an UpsC var, one expressed the unique UpsE linked
transcript (IT4var4, var2CSA), and for one parasite, the Ups
category of the dominant var transcript has yet to be determined
(Figure 4). The remaining parasite in the panel, 2G2, is knobless
and was employed as a negative binding control (Table 1) [54].
Most parasites in the panel expressed distinct dominant var
transcripts, except two subclones (P6G2 and P5B6) expressed
IT4var31, and two others (P6A8 and 4E12) expressed IT4var37/
AFBR6 as either the dominant or secondary var transcript (Figure 3
and Table 1).
To confirm the presence of knobs on the IE surface, which are
known to be important in PfEMP1 anchoring and infected
erythrocyte binding [41,54,55], parasites were tested for tran-
scription of the knob associated histidine rich protein (kahrp
+)b y
RT-PCR and floated by gelatin sedimentation (gelatin
+). All
parasites in the panel were positive in both assays, except for the
negative control 2G2 parasite line, which lacks kahrp and therefore
sedimented in gelatin. In addition, the three rosette-forming UpsA
parasites all transcribed kahrp but sedimented in gelatin because
they were originally isolated on the basis of their property to
sediment in Ficoll (Table 1). To confirm the identity of var gene
transcription at the time of binding assays, RNA was harvested
Figure 1. Derivation of parasite lines for phenotypic analysis. A panel of 19 P. falciparum parasite lines (clear boxes) was generated from
parental laboratory lines (black boxes) using limited dilution cloning or various selection techniques. All parasite lines express a unique predominant
var transcript by qRT-PCR or monoclonal antibody reactivity except for two lines (a) that both express IT4var31.
doi:10.1371/journal.ppat.1002032.g001
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in the absence of selection for more than 70 parasite divisions, and RNA was harvested. The profile of var gene expression was measured by qRT-PCR,
using specific primers to the IT4var genes. After 70 cycles, the parasite culture had nearly completely switched away from IT4var14/A4var and
predominantly expressed three var transcripts (IT4var26, IT4var31, and IT4var37), plus many genes at lower levels. Gene expression was normalized to
the housekeeping control gene adenylosuccinate lyase (asl). The A4 primer set is arranged along the x-axis by Ups category: UpsA (red), UpsB (blue),
UpsC, (yellow), and UpsE (gray) groups, as well as three genes for which the Ups type has not been determined (white).
doi:10.1371/journal.ppat.1002032.g002
Table 1. Phenotypic and var transcriptional profile of parasite panel.
qRT-PCR initial typing
c qRT-PCR: binding
d
Parasite Gelatin
a kahrp
b major transcript % transcripts major transcript % transcripts
R29 - + nd nd nd nd
Pf13 - + nd nd nd nd
VarO - + nd nd nd nd
CS2 ++ nd nd var4 99%
A4ultra ++ nd nd var14; var24 25%;6%
P6D12 ++ var39; var67 60%; 36% var39; var67 74%;21%
P6A1 ++ var11 92% var11 81%
P4H12 ++ var44 100% var44 100%
P2E11 ++ var33 90% var33 96%
ItG-ICAM-1 ++ nd nd var16 60%
P6G2 ++ var29;var31 57%;42% var31 97%
P5B6 ++ var31 100% var31 89%
P5C2 ++ var43/var66;var31 71%;19% var43/66 78%
3G8 ++ var1 99% var1 98%
P6A8 ++ var24;var37 79%;16% var24;var37 66%;32%
4E12 ++ var37 94% var37 95%
P5F12 ++ var21;var59 70%;30% var21;var59 73%;27%
P3G5 ++ var10;var32 52%;48% var10;var32 80%;19%
2G2 - - var20 88% var20 96%
aThe ability of infected erythrocytes to float in 0.7% gelatin was used as a surrogate for knob positivity.
bIndicates whether the knob-associated histidine rich protein gene could be amplified from cDNA.
cProfiling of var transcription was performed after initial parasite expansion following limited dilution cloning. Transcripts representing greater than 5% of the total var
messages are listed.
dProfiling of var transcription was repeated at the time of infected erythrocyte binding assays as above. nd - not done.
doi:10.1371/journal.ppat.1002032.t001
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For these assays, thawed parasite stabilates were grown for 4 to 5
cycles to generate sufficient parasite material, and parasites were
generally analyzed a total of 18–20 cycles from initial parasite
cloning. In general, the dominant var transcript did not change
between the initial qRT-PCR characterization performed after
limited dilution cloning and the second round of -typing done at
the binding assay (Table 1). In only one parasite line, P6G2, the
previous dominant transcript was replaced by the secondary var
transcript that was present before freezing (Table 1). At the time of
the binding analysis, the average fold transcription of dominant var
transcripts relative to the asl housekeeping gene was 14.2 (range
2.8–28.1). Furthermore, most parasite lines were significantly
enriched for a single predominant var transcript (Figure 3), and
only 8 parasite lines contained a secondary var transcript at greater
than 5% of the total var transcripts (Table 1). In most cases, the
secondary transcript was present at much lower levels than the
dominant var transcript. Thus, var gene transcription was stable
over the short-term culture period used to perform these assays.
For the three UpsA variants, PfEMP1 expression was established
by flow cytometry with specific monoclonal antibodies to be 79%
or higher using conservative gating criteria (Figure S1). Further-
more, all three lines formed rosettes in O-type RBCs: R29
(rosetting rate=37%, 89% mAb reactivity R29), VarO (rosetting
rate=73%, 79% mAb reactivity VarO), Pf13 (rosetting
rate=52%, 94% mAb reactivity Pf13_0003). Therefore, all of
the parasites in the panel were highly homogenous for one or two
var transcripts, and UpsA parasite lines were highly pure for a
single expressed PfEMP1 variant.
CD36 binding of infected erythrocytes is highly predicted
by the type of CIDR domain in PfEMP1 proteins
To investigate whether infected erythrocyte binding to CD36
could be predicted from sequence information and binding studies
of isolated CIDR domains [46], the complete panel of parasite
lines was analyzed for binding to both CHO745-CD36 and
immobilized CD36 recombinant protein. Because rosettes of
uninfected red blood cells can interfere with binding or make
bound IEs more susceptible to disruption during washing stages,
the rosettes of the three UpsA variants were first disrupted using
heparin sulfate prior to binding analysis. Previous work has shown
that sulfated glycoconjugates can enhance binding to CD36 on cell
surfaces [56]. Therefore, as a control for the three rosetting
parasite lines, all of the parasites in the panel were treated with
heparin sulfate and tested for binding to immobilized CD36
recombinant protein. Heparin sulfate treatment greatly dimin-
Figure 3. Analysis of var gene transcription in parasite lines at the time of infected erythrocyte binding assays. RNA was harvested
from ring stage parasites in the same cycle that infected erythrocyte binding assays were performed, and var expression profiling was performed by
qRT-PCR. Most parasite lines expressed a single dominant var gene transcript, and some parasite lines had a secondary var transcript. Other var genes
were expressed at negligible levels. Gene expression was normalized to the housekeeping control gene adenylosuccinate lyase (asl). The scale of the
Y-axis is the same for all parasite lines. The A4 primer set is arranged along the x-axis by Ups category; UpsA (red), UpsB (blue), UpsC, (yellow), and
UpsE (gray) groups, as well as three genes for which the Ups type has not been determined (white). The name of each parasite line is indicated at the
right of its respective transcription profile.
doi:10.1371/journal.ppat.1002032.g003
Figure 4. Schematic representation of var transcription in the parasite panel and summary binding to CD36 and ICAM-1 receptor
proteins. Parasite name, predominant var transcript(s) by qRT-PCR, Ups categorization, and predicted protein architecture are shown for parasite
lines included in the panel, with the exception of the negative binding control line (2G2). Predicted binding of native PfEMP1 to CD36 and ICAM-1
receptor proteins based on previous analysis of CIDR::CD36 [46] and DBLb::ICAM-1 interactions [44] are shown, along with observed binding to these
receptor proteins in both cell and recombinant protein platforms. Low, moderate, and high binding levels are indicated in gray-scale: clear=,15 IE
per 100 CHO cells, ,80 IE per mm
2; light gray=16–50 IE per 100 CHO cells, 81–500 IE per mm
2; dark gray=51–100 IE per 100 CHO cells, 501–1000 IE
per mm
2; black=.101 IE per 100 CHO cells, .1000 IE per mm
2. Ukn means the Ups type or binding behavior is unknown.
doi:10.1371/journal.ppat.1002032.g004
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(Figure S2), but had minimal effect on infected erythrocyte binding
to immobilized CD36 recombinant protein. Overall, parasites had
comparable binding levels in the presence or absence of heparin
sulfate (Figure S2). In addition, two non-rosetting, CD36 binding
parasite lines (A4ultra and ItG-ICAM-1) were tested for binding to
CHO745-CD36 cells in the presence or absence of heparin sulfate.
Similar to what has been reported previously [56], sulfated
glycoconjugates increased IE binding to CHO745-CD36 (Figure
S3). Because heparin sulfate may slightly enhance IE adhesion to
CHO-CD36 and did not modify IE adhesion to immobilized
CD36, the binding assay was then repeated for all of the non-
UpsA parasites in the absence of sulfated glycoconjugates. In
contrast, binding of the three UpsA lines to CHO-CD36 and
immobilized CD36 was repeated in the presence of sulfated
glyconjugates to prevent infected erythrocyte rosetting interfering
with the binding results.
Overall, there was a significant correlation between CHO745-
CD36 and spotted CD36 protein formats (Figure 5, Spearman’s
Rho=0.75, p,0.001). Although the level of CD36 binding varied
between parasite lines, most of the parasites bound CD36, with the
exception of UpsA/E groups (Figure 6). The three UpsA parasites
were at the lower spectrum of CD36 binding in both cell and
recombinant protein binding assays, and were basically indistin-
guishable from the negative control, knobless parasite line, and the
UpsE parasite line that does not bind CD36 (Figure 6).
Furthermore, CD36 binding was highly predicted by the type of
CIDR1 domain in the PfEMP1 head structure (Figure 4). Indeed,
only two parasites in the panel that were predicted to bind CD36
did not bind to CHO-CD36 cells. However, both exceptions
(P4H12 and P3G5) bound at a low level to 50 mg/mL rCD36, but
not to 5 mg/mL rCD36 (Figure 5), and therefore may be lower
affinity CD36 binders. In group-wide comparisons, UpsB and
UpsC had a higher mean CD36 binding level than UpsA. This
difference was significantly different in the immobilized CD36
binding assay and between the UpsC and UpsA groups in the
CHO-CD36 assay, and just missed significance between the UpsB
and UpsA groups in the CHO-CD36 assay (Figure 6). Taken
together, infected erythrocyte binding was highly predictable
based on the type of CIDR domain (Figure 4), and the UpsA
group appears to be under less selection to bind CD36.
ICAM-1 binding was strongly associated with larger,
DBLb containing PfEMP1 proteins
To test whether ICAM-1 binding was associated with larger
PfEMP1 proteins containing DBLb domains [44], the parasite
panel was analyzed for binding to CHO745-ICAM-1 and
recombinant ICAM-1 protein. Again, to prevent rosettes from
interfering with the binding analysis, the three UpsA parasite lines
were treated with sulfated glycoconjugates prior to binding
analysis, and as a control, two non-rosetting, ICAM-1 binding
parasite lines (A4ultra and ItG-ICAM-1) were tested for ICAM-1
binding in the presence or absence of sulfated glycoconjugates.
Sulfated glyconjugates reduced binding of A4ultra in the
CHO745-ICAM-1 assay and binding of both parasite lines to
spotted ICAM-1 recombinant protein (Figure S3), similar to what
has been reported before [56]. Because of the potential for sulfated
glyconjugates to interfere with ICAM-1 binding in the cell and
recombinant protein assays, the three UpsA parasite lines were not
considered in the ICAM-1 binding analysis.
Figure 5. Infected erythrocyte binding to CD36 and ICAM-1. Parasites in the panel were assessed for binding to transfected CHO745 cell lines
or recombinant proteins. (A) Infected erythrocyte binding to CHO745 cell transfectants expressing human CD36 receptor. (B) Infected erythrocyte
binding to recombinant CD36-Fc protein immobilized on polypropylene substrate at 50 mg/mL and 5 mg/mL concentrations. (C) Infected erythrocyte
binding to CHO cell transfectants expressing human ICAM-1 receptor. (D) Infected erythrocyte binding to recombinant ICAM-1-Fc protein
immobilized on polypropylene substrate at 100 mg/mL and 50 mg/mL. The two parasite lines that express IT4var31 as the predominant var gene are
indicated by boxes with horizontal bars. An arbitrary threshold for positive binding (grey dashed line) was calculated as the mean level of infected
erythrocyte binding plus two standard deviations either to untransfected CHO745 cells or to spots containing 2% bovine serum albumin, respectively.
Error bars represent the range of binding between two replicate experiments.
doi:10.1371/journal.ppat.1002032.g005
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(.2 IEs/CHO745-ICAM-1), three bound at moderate level (0.5–
2 IEs/CHO745-ICAM-1), and the remaining parasite lines bound
at a low level or did not bind ICAM-1 (Figure 5). While there was
good consistency between the cell and recombinant protein assays
for the two high level ICAM-1 binders, there was more
discordance for weaker ICAM-1 binders (Figure 5). Only three
parasite lines bound ICAM-1 in both platforms (3G8, ItG-ICAM-
1, and A4ultra), and two parasite lines that bound at a moderate
level to CHO745-ICAM-1 did not bind to immobilized ICAM-1
protein (Figure 5). Notably, both parasite lines express the
IT4var31 transcript, which has been suggested to be a weaker
ICAM-1 binding variant that is trypsin-resistant [57,58]. To
confirm whether binding was trypsin-resistant, P5B6-infected
erythrocytes expressing IT4var31 were treated with 1 mg/mL
trypsin prior to ICAM-1 binding analysis. Trypsin treatment
reduced CD36 binding and increased binding to recombinant
ICAM-1 (Figure S4), and therefore may have cleaved or truncated
the PfEMP1 head structure. The increase in ICAM-1 binding
could be blocked by anti-ICAM-1 antibody (mAb 15.2) and not by
anti-CD36 isotype control antibody (FA6-152) (Figure S4). In
contrast, identical trypsin treatment of 3G8 (IT4var1) and ItG-
ICAM-1 parasite lines (IT4var16) abolished binding to both CD36
and ICAM-1 (data not shown). Thus, as predicted from binding of
the isolated DBLb domain [58], IT4var31 was associated with
ICAM-1 binding, but the cell binding assay was more sensitive
than immobilized protein in detecting this interaction. Two of the
parasite lines also bound at a low level to immobilized ICAM-1
recombinant protein but did not bind CHO745-ICAM-1. Thus,
there may be differences in the sensitivity of the two platforms to
detect lower affinity ICAM-1 interactions, or some of the low level
binding interactions may not have been specific.
Overall, ICAM-1 binding was strongly associated with larger
PfEMP1 proteins that contained a DBLb domain. Seven of the ten
parasites lines that expressed a dominant var transcript containing
a DBLb domain bound to ICAM-1 in either the cell or
recombinant protein platform (Figure 4), and parasite lines
without a DBLb either bound extremely weakly or did not bind
ICAM-1 (Figure 6). This difference was significant in the
immobilized ICAM-1 assays (1-tailed t-test, p=0.020) and just
missed significance in the CHO745-ICAM-1 assay (1-tailed t-test,
p=0.103). Recently, there has been a reclassification of DBL and
CIDR domains into additional subtypes based on a comparison of
7 parasite genomes in which DBLb domains were subclassified
into 13 sub-types [10]. Of interest, all three parasites that bound in
both the CHO-ICAM-1 and immobilized ICAM-1 assays
expressed a DBLb5 domain (Figure 4). To investigate if DBLb5
could be a marker for ICAM-1 binding, we reanalyzed the
recombinant DBLb-ICAM-1 binding data [44]. In the IT4
parasite genotype, 7 of 23 DBLb domains bound ICAM-1. Of
the 7 ICAM-1 binders, 6 were DBLb5 sequences, and there were
no DBLb5 domains that did not bind ICAM-1 (Figure 7).
Significantly, an ICAM-1 binding parasite from India (JDP8-
ICAM-1, AY028643) [59] also uses a DBLb5 domain to bind
ICAM-1 (Figure 7). The fact that ICAM-1 binding was 100%
predictable in the IT4 parasite genotype, and that a different
parasite isolate from India also uses DBLb5 for binding, strongly
supports this domain as a marker for ICAM-1 binding. There are
Figure 6. Infected erythrocyte binding to CD36 and ICAM-1. Dot plots show averaged results of replicate infected erythrocyte binding
experiments for individual cloned parasites lines contained in the panel (Figure 5) and grouped either by (A, B) Ups classification of major var
transcript or (C, D) presence of DBLb adhesion domain in the major var transcript. Mean infected erythrocyte binding was compared between groups
using non-paired, 1-tailed t-tests. P-values are indicated according to the 95% confidence interval. An arbitrary threshold for positive binding (grey
dashed line) was calculated as the mean level of infected erythrocyte binding plus two standard deviations either to untransfected CHO745 cells or to
spots containing 2% bovine serum albumin, respectively. (A) Infected erythrocyte binding to CHO745-CD36. (B) Infected erythrocyte binding to
recombinant CD36-Fc fusion protein immobilized in 10 mL spots at 50 mg/mL onto polystyrene substrate. (C) Infected erythrocyte binding to
CHO745-ICAM-1. (D) Infected erythrocyte binding to recombinant ICAM-1-Fc fusion protein immobilized in 10 mL spots at 100 mg/mL onto
polystyrene substrate.
doi:10.1371/journal.ppat.1002032.g006
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parasite genotype and one from the 3D7 parasite genotype [45],
but several other DBLb3 sequences did not bind ICAM-1 as
recombinant proteins (Figure 7). Taken together, ICAM-1 binding
was strongly associated with the DBLb domain, and the DBLb5
marks a category of larger PfEMP1 variants that encode this
adhesion property.
Infected erythrocyte binding to additional receptors was
rare
Infected erythrocytes have been reported to bind a number of
host receptors [20], but for the most part binding has only been
tested on one or a few parasite lines. Using transfected cells or
recombinant proteins, the 19 parasite lines were assayed against 8
additional receptors: Endothelial Leukocyte Adhesion Molecule 1
(E-selectin), Vascular Cell Adhesion Molecule 1 (VCAM-1), CHO
receptor ‘‘X’’, Hyaluronan Binding Protein 1 (HABP1), Platelet
Endothelial Cell Adhesion Molecule-1 (CD31/PECAM-1),
Thrombospondin-1 (TSP-1), CSA, and Fractalkine. Whereas a
few parasite lines bound at a low level to TSP-1 and CHO-ELAM-
1, there was negligible binding to most receptors tested (Figure 8).
Two of the UpsA parasites (Pf13 and VarO) bound at a low level
to HABP1, CD31, and CSA. However, binding of UpsA parasites
was performed in the presence of sulfated glycoconjugates to
disrupt rosettes, and they also had higher background binding to
bovine serum albumin (BSA) employed as a blocking agent for
binding assays (Figure 8, and data not shown). As expected, the
strongest CSA-binder in the panel was the CS2 parasite line in
both the CHO-K1 cell and CSA spot formats (Figure 8). CS2
expresses the VAR2CSA PfEMP1 protein that has been shown to
be the primary PfEMP1 variant associated with CSA binding
[60,61]. Most of the other receptors tested did not support strong
adhesion of infected erythrocytes in these binding assays and it is
questionable whether all of the observed weak interactions are
physiologically relevant.
Discussion
PfEMP1 proteins/var genes are classified into three main
subfamilies (UpsA, UpsB, and UpsC) that have different host
expression profiles [35–37,39]. Both binding strength and
specificity of IEs are likely to influence disease severity during an
infection; therefore, it is important to understand whether PfEMP1
subfamilies have evolved specialized properties for distinct host/
biological niches. Studies of malaria during pregnancy have
demonstrated how a specific PfEMP1 variant can precipitate
severe disease in otherwise immune women by altering IE tropism
for the placenta [14,29,62]. Although VAR2CSA appears to be
unique in its ability to confer high-affinity binding to CSA in the
placenta [60,61,63], it offers a paradigm for the role of specific
PfEMP1s in disease. UpsA classified PfEMP1 proteins are
frequently observed in young children with limited anti-malaria
immunity or experiencing severe malaria [35–39]. Unlike
VAR2CSA, the adherence characteristics of UpsA proteins are
poorly understood and limited largely to predictions of binding
based on studies of isolated adhesion domains [44–46]. To
investigate a correlation of PfEMP1 binding specificities with
disease outcome, the binding characteristics of at least a
representative sample of the three main subgroups (UpsA, UpsB
and UpsC) have to be known. In this study, we employed a panel
of different PfEMP1 types to test binding predictions based upon
studies of single PfEMP1 domains.
While UpsA variants appear to be commonly expressed in early
childhood infections and non-immune individuals [35–39], very
little is known about what may account for this preferential
expression in the malaria naı ¨ve. Investigation is hampered because
most P. falciparum infections contain a mixture of PfEMP1 variants
and even minor parasite subsets may obscure binding analysis. In
addition, gene silencing of UpsA variants has been observed upon
in vitro adaptation [64]. In long term in vitro adapted parasite
cultures grown without selection for specific var gene expression,
UpsA variants were expressed at a low level, and an UpsB
(IT4var31/C18var) and an UpsC (IT4var37/AFBR6) var gene
appeared to be the most common switch events. Both were also
found to be frequently activated in previous clonal analyses in this
strain background [7,52] and thus may have a higher ‘‘on’’ rate
under in vitro culture conditions. One study found that var genes in
central chromosome regions had lower switch rates than those in
telomeric regions [65], but inherent differences were not
consistently observed in a different parasite line [52]. The
chromosome positions of IT4var31 (UpsB) and IT4var37 (UpsC)
have not been mapped and therefore we cannot comment on
whether this observation held true in our study or not. However,
our findings indicate that promoter type is not the main
determinant of var gene ‘‘on’’ rate as far as UpsB and UpsC type
var genes are concerned. In the case of UpsA variants, the
promoter type did seem to determine var gene expression rate by
significantly reducing it. To overcome these problems, we used
specific monoclonal antibodies to generate three distinct UpsA
parasite lines of high purity for the parasite panel.
In epidemiological studies, CD36 and ICAM-1 binding are the
most common adhesion traits in the parasite population [17,19],
Figure 7. Phylogentic comparison of DBLb domains that bind
or do not bind ICAM-1. A tree of DBLb sequences was constructed
using new domain boundaries [10] and was used to reanalyze the
DBLb-ICAM-1 interaction. Bootstrap values over 70% are indicated with
open circles. Recombinant DBLb proteins from the IT4 parasite
genotype that were previously shown to bind ICAM-1 are indicated
with red lines, non-binding sequences have blue lines, and untested
sequences are indicated with black lines [46]. Two ICAM-1 binding
sequences from the 3D7 and JD8 parasite isolates are also included
[45,59]. Ups A–C grouping is indicated next to the gene name, as well as
the DBL subclassification according to Rask et al [10].
doi:10.1371/journal.ppat.1002032.g007
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family is only partially understood [44–46,58,66]. In the parasite
panel, CD36 was by far the most common binding partner,
followed by ICAM-1 and TSP-1. CD36-binding was nearly 100%
predictable and was always associated with a CIDRa type domain
in the protein head structure, while the three UpsA variants had
different sequence types (CIDRc and CIDRd) and did not bind
CD36 or only bound at a low level. Thus, in the absence of a
CIDRa domain, other potential CD36 ligands [67,68] were
unable to compensate for infected erythrocyte binding. Moreover,
the level of CD36 binding differed between isogenic parasites
expressing different PfEMP1 variants, suggesting that PfEMP1
sequence variability or surface expression levels have an important
role in influencing the overall binding affinity of infected
erythrocytes.
The UpsA group contains three different types of CIDR1
sequences (a1, c,o rd) [10,12,40,46]. Although the three UpsA
parasites in the panel were all selected for rosetting, ‘‘rosetting’’
and ‘‘non-CD36 binding’’ can exist as independent phenotypes.
For instance, the non-CD36 binding CIDR domains identified in
this study may potentially be found in non-rosetting group A
genes, and there is evidence that CD36 is able to act as a host
receptor for rosetting in the Malayan Camp parasite strain and
some field isolates [69]. This parasite panel did not contain any
representation of the CIDRa1 subtype, which is found in
approximately half of UpsA proteins [10]. However, it has
previously been shown that recombinant CIDRa1 subtype
domains do not bind CD36 [46], and CD36 selection led to loss
of expression of an UpsA gene in a mixed parasite culture that
expressed a CIDRa1 subtype [70]. Taken together, the results
suggest the UpsA group is not under strong selection for CD36
binding, and it will be interesting to determine if the UpsA protein
head structure is selected for specific binding properties that
support microvasculature sequestration by a mechanism different
Figure 8. Infected erythrocyte binding to other candidate cytoadhesion receptors. Parasites in the panel were assessed for binding to
transfected CHO745 cell lines or recombinant proteins. (A) Infected erythrocyte binding to CHO cells expressing chondroitin sulfate A (CHO-K1), E-
selectin (CHO745-ELAM-1), or vascular leukocyte adhesion molecule 1 (CHO745-VCAM-1). (B) Infected erythrocyte binding to immobilized
chondroitin sulfate A (CSA) and the recombinant proteins TSP-1, HABP1, CD31, endoglin, and fractalkine. All proteins and CSA were immobilized on
polystyrene substrate at 50 mg/mL. Infected erythrocyte binding to transfected cell lines were corrected by subtracting background binding to
untransfected CHO-745 cells. Binding to recombinant proteins was corrected by substracting binding to bovine serum albumin, which was employed
as the blocking agent in all assays. An arbitrary threshold for positive binding (grey dashed line) was calculated as the mean level of infected
erythrocyte binding plus two standard deviations either to untransfected CHO745 cells or to spots containing 2% bovine serum albumin, respectively.
Error bars represent the range of binding between two replicate experiments.
doi:10.1371/journal.ppat.1002032.g008
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erythrocyte rosetting [71,72], but the UpsA group may encode
other adhesion properties [47].
After CD36, ICAM-1 is one of the most common adhesion
properties, and the two receptors synergize to mediate infected
erythrocyte binding under flow [22,23]. ICAM-1 is upregulated on
brain endothelium during malaria infections and has been
proposed to be a potential cerebral sequestration receptor [24].
ICAM-1 binding has previously been mapped to the DBLb
domain [44,45,58,59,73]. Our study confirms this association as
the DBLb5 domain was 100% associated with ICAM-1 binding in
both parasite lines and recombinant proteins. It also shows that
not all DBLb domains bind to ICAM-1. In future work using
patient samples it may be interesting to investigate how well
transcription of var genes containing a DBLb5 domain can predict
ICAM-1 binding. Overall, this study identifies a category of large
UpsB and UpsC PfEMP1 containing CIDRa and DBLb5 subtype
domains that were 100% associated with CD36 and ICAM-1
binding. In a comparison of var gene repertoires from 7 parasite
strains, the CIDRa and DBLb5 domains were always found
together in tandem arrangement (27 of 399 full or partial length
var genes), and the DBLb5 domain was never associated with a
predicted ‘‘non-CD36 binding’’ CIDR domain. This suggests the
association has not evolved by chance and that the CIDRa-
DBLb5 domain combination may be under dual selection for
binding to CD36 and ICAM-1. Both receptors are co-displayed on
many of the same cell types (endothelial, monocyte, and dendritic
cells) and may provide the parasite opportunities to manipulate
host cells [74,75], thus contributing to their strong selection in the
PfEMP1 repertoire. There were also a few DBLb3 domains that
bound to ICAM-1, but these were found in association with both
CD36 binding and non-CD36 binding CIDR domains. Thus,
CD36 and ICAM-1 have left strong signatures of selection
detectable by PfEMP1 adhesion domain sequence classification,
despite the extensive sequence diversity in the family.
Other PfEMP1 adhesion properties examined appear to be
much rarer or may only play an additive role in overall binding
affinity. Nearly all PfEMP1 proteins have four or more
extracellular domains. In addition to undefined binding properties,
other PfEMP1 domains may also function as ‘‘spacers’’ to position
the PfEMP1 head structure and adjacent DBLb away from the IE
surface in order to engage CD36 and ICAM-1 [76]. A potential
caveat is that binding was performed under static adhesion
conditions, and individual host recombinant proteins were
employed in the protein binding assays. However, all host
receptors examined were originally defined under similar static
adhesion conditions. Furthermore, static adhesion assays are
capable of detecting host receptor interactions that support both
rolling (ICAM-1, TSP-1) and stationary (CD36) cytoadhesion of
infected erythrocytes under flow conditions [21]. Cooperative
binding is likely necessary to mediate firm adhesion under flow
[21–23], but from this analysis CD36 binding is under greatest
selection and contributes the greatest binding avidity in different
PfEMP1 proteins.
These results reveal a fundamental difference in CD36 binding
between Ups groups that has important implications for how
parasites establish infections in individuals of varying levels of
immunity. UpsA proteins are more commonly expressed in
children with low immunity [35,36,39]. Later, as malaria
immunity develops, it may be significant that the proportion of
non-UpsA types and CD36 binding variants increases. It is
interesting to speculate that non-CD36-binding parasites may
experience a selective advantage over their CD36-binding
counterparts in patients with limited exposure to malaria. CD36-
binding parasites are thought to manipulate both host innate and
adaptive immune responses by interacting with monocytes and
dendritic cells [74,75,77,78]. In the malaria naı ¨ve, these
interactions may be less important, or UpsA variants may possess
other advantages or means of host manipulation. While UpsA
variants have not been clearly associated with disease in all studies
[79], they are more abundant in patients with severe malaria
[80,81] and have been associated with cerebral malaria infections
in children in Mali [38]. A greater proportion of UpsA variants in
early infections could potentially contribute to why CD36 binding
levels are very low in children with severe malaria anemia [17,19],
or these variants could alter the pattern of sequestration to
microvascular beds, such as brain endothelium, where CD36
binding levels are extremely low [24]. Therefore, it will be
important to learn more about this group of proteins.
In conclusion, the PfEMP1 protein family has diversified under
dual selection to evade host immunity and mediate infected
erythrocyte binding. The development of a parasite panel enriched
for distinct PfEMP1 expression from the major Ups groups has
facilitated the testing of binding predictions, and may have
potential applications for investigating immune acquisition to the
family of proteins. This comparative analysis demonstrates the
predictability of P. falciparum-IE binding to the two major
cytoadhesion receptors CD36 and ICAM-1 and provides new
insight into how natural selection may be shaping the PfEMP1
binding repertoire to exploit distinct host niches of varying anti-
malaria immunity.
Materials and Methods
Ethics statement
Human blood was used for P. falciparum culture in this study.
Donor blood was obtained from healthy volunteers under a
minimal risk, standardized, Institute protocol (protocol number
HS013) that was approved by the Western Institutional Review
Board. Written informed consent was obtained from all blood
donor study participants.
P. falciparum culture conditions
The three UpsA variants were isolated by gelatin sedimentation
followed by positive selection with specific monoclonal antibodies
against the respective NTS-DBLa domain. The VarO parasite
clone was generated from the Palo Alto strain as described by
rosette enrichment and selection with monoclonal antibody D15–
50 [82]. The R29 parasite (IT4 parasite strain) has been described
previously [6,7,83]. Highly enriched parasite cultures expressing
the R29 PfEMP1 protein and Pf13 (3D7 strain) were isolated by
similar methodologies to the VarO parasite line using rosette
enrichment and specific monoclonal antibodies against the R29-
DBLa domain (3B13C5) or the Pf13_0003-DBLa domain (J3.21)
[53]. The ItG-ICAM-1 parasite line was derived by ICAM-1
selection [18], CS2 by CSA selection [84], and the 3G8, 4E12,
and 2G2 parasite lines by limited dilution cloning [52]. The
remaining parasite lines were derived from IT4/25/5 clone A4 [6]
by limited dilution cloning. Infected erythrocytes were cultured
under standard conditions using human O red blood cells (RBCs)
in RPMI-1640 medium (Invitrogen) supplemented with 10%
pooled human A
+ serum and an atmosphere of 5% CO2,5 %O 2,
and 95% N2 at 37uC. Synchronization of parasite growth was
achieved by treatment with 5% sorbitol in PBS. Gelatin
sedimentation assays were performed in RPMI-1640 medium
containing 0.7% porcine gelatin (Sigma) for 45 minutes at 37uC.
Enrichment of infected erythrocytes (IE) in the gelatin supernatant
was determined by counting .300 methanol-fixed, Giemsa-
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visualized after infected red blood cell nuclei were stained by
ethidium bromide. The rosetting rate was calculated by deter-
mining the percentage of rosette-forming infected cells in the
mature parasite population.
Chinese hamster ovary cell culture conditions
CHO-K1, CHO745, and CHO745 transfectants expressing
CD36, ICAM-1, E-selectin, or VCAM-1 were cultured in F-12
Kaighn’s medium supplemented with 10% fetal calf serum and
0.5 mg/mL geneticin (Gibco). The CHO745 transfectants were
described in Buffet et al. [85]. Recombinant protein surface
expression was monitored by flow cytometry on a monthly basis
using receptor-specific monoclonal antibodies (R&D Systems), and
cells were replaced if the percentage of transfected cells or mean
fluorescence intensity diminished by greater than 20%.
Limited dilution cloning of parasite lines
An A4 parasite clonal line [6] was grown continuously under
standard conditions for more than 70 growth cycles in the absence
of overt selection. IEs were periodically enriched for knob
expression by floatation in 0.7% porcine gelatin (Sigma) dissolved
in RPMI-1640 (Invitrogen) at 37uC. Prior to limited dilution
cloning, RNA was collected and a profile of var transcription was
determined by quantitative real-time polymerase chain reaction
(qRT-PCR) using a primer set designed to amplify unique
sequence tags within the repertoire of IT4 var genes [86].
Individual infected erythrocytes were obtained on two separate
occasions by limited dilution cloning after more than 78 and 84
cycles of continuous parasite growth, respectively, at a seeding rate
of 0.5 infected erythrocytes per well. Initial frozen stabilates were
collected after approximately 14–15 cycles of growth and parasite
lines were typed for var gene expression by qRT-PCR.
Determination of var transcription by qRT-PCR
The determination of var gene transcription profiles was
performed using primers and PCR conditions as previously
described [86]. In brief, RNA was extracted in Trizol LS
(Invitrogen) from ring stage parasites at ,6–12 hours post-
invasion and purified on RNeasy Micro columns with on-column
DNaseI treatment (QIAGEN) according to manufacturer’s
protocols. cDNA was synthesized from 4 mg total RNA using
Multi-Scribe reverse transcriptase (Applied Biosystems) and one
half of this material was used for each real-time reaction against
the complete set of primers. Real-time reactions were performed
on an ABI Prism 7500 thermocycler at optimized final primer
concentrations of 0.05 mM-0.5 mM using Power-SYBR Green
Master Mix in 20 mL reaction volumes under the following PCR
conditions: 50uC for 1 min, 95uC for 10 min, then 40 cycles of
dissociation, annealing, and extension at 95uC for 15 sec, 52uC for
15 sec, and 60uC for 45 sec, respectively. Relative transcription
was determined by normalization to the adenylosuccinate lyase
(ASL, PFB0295w) control housekeeping gene. After optimizing
primer efficiencies, residual primer bias was corrected by
calculating the average difference in CT values between each
optimized IT4 var primer pair and ASL using genomic DNA as
template to provide a final normalized correction.
Infected erythrocyte binding assays
Parasite RNA was collected and binding assays performed
within the same growth cycle to accurately assess var transcription
at the time of the binding assay. For binding assays, individual
CHO cell lines were grown to subconfluent levels on 60-mm tissue
culture-treated dishes (BD Falcon) and recombinant proteins were
immobilized by overnight incubation onto 60-mm polystyrene
dishes (Corning). The following proteins were analyzed: CD36-Fc
(R&D Systems), ICAM-1-Fc (R&D Systems), HABP1/gC1qR-6x
HIS (R&D Systems), Fractalkine-6x-HIS (R&D Systems), CD31/
PECAM-1 (R&D Systems), TSP-1-10x HIS (R&D Systems), and
CSA (Sigma). All proteins and CSA were applied at 50 mg/mL
except for CD36 and ICAM-1, which were additionally applied at
5 mg/mL and 100 mg/mL. On the day of the assay, dishes
containing CHO cells were washed twice with pre-warmed cell
binding medium (BMcell: RPMI-1640 medium containing 0.1%
bovine serum albumin, pH 7.2) and protein spots were blocked
with 2% bovine serum albumin for 45 min at 37uC, then washed
twice with pre-warmed protein binding medium (BMprotein:
RPMI-1640 medium containing 0.1% bovine serum albumin,
pH 6.8). Infected erythrocytes (3-8% parasitemia) were washed
and resuspended to 1% hematocrit in either BMcell or BMprotein
then overlayed onto CHO cells or spotted onto immobilized
proteins, respectively, and incubated for 1 hr at 37uC. Prior to
binding assays, rosettes in the three UpsA parasite lines were
disrupted in binding medium containing 100 Units/mL heparin
sulfate (Sigma). The same conditions were used when testing the
effect of heparin sulfate on all of the parasites in the panel. In
additional assays to test the effect of sulfated glycoconjugates on IE
binding, either 10 mg/mL dextran sulfate (MW .500,000; Sigma)
or 100 Units/mL heparin sulfate were included during binding
assays. Non-binding erythrocytes were removed by gently flooding
each dish with warm binding medium, rocking the dish back and
forth several times to resuspend non-binding erythrocytes, then
pouring off and replacing the medium. The initial washing
procedure was performed on CHO745 cells and 2% BSA spots
and was repeated until non-binding erythrocytes were sufficiently
removed by observation under 400X magnification. The remain-
ing cells and spots then received the same number of washes. For
quantification, dishes were fixed in 1% glutaraldehyde for 20 min
at room temperature, then stained with 1X Giemsa for 15
minutes. Binding was quantified by determining the number of IE
adhering to at least 300 cells under 1000X magnification or the
number of IE per mm
2 in 4 random fields under 400X
magnification. All binding assays were repeated in duplicate.
Flow cytometry analysis
Trophozoite stage infected RBCs were incubated for one hour
at room temperature with specific monoclonal mouse antibodies
against R29var NTS-DBLa (mAb 3B13C5, 1:500) Pf13_0003
NTS-DBLa (mAb J3.21, 1:20), or VarO NTS-DBLa (mAb D15-
50, 1:20). Antibody labeling was detected with goat anti-mouse
IgG-R-Phycoerythrin (Sigma) (1:20) for 30 minutes. Infected
erythrocyte nuclei were detected with SYTO 61 DNA dye
(Invitrogen) (1:1000) added with the secondary antibody. Stained
cells were washed in PBS and analyzed on an LSRII FACS
machine (BD Biosciences). Analysis was performed using FlowJo 8
(Tree Star, Inc).
Supporting Information
Figure S1 Flow cytometric analysis of infected erythrocytes
expressing UpsA PfEMP1 proteins. Infected erythrocytes were
labeled with specific monoclonal antibodies made against the
NTS-DBLa domain in R29var, Pf13_0003, or VarO PfEMP1
proteins. FACS histograms of gated infected erythrocytes labeled
with monoclonal antibodies (blue lines) or without (red lines). The
rosetting rate (RR), or the ability of infected erythrocytes to bind
non-infected RBCs at the time of antibody labeling, is indicated in
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uninfected red blood cells.
(TIF)
Figure S2 Binding to immobilized CD36 in the presence of
heparin sulfate. (A) Infected erythrocyte binding to triplicate spots
of immobilized CD36 protein (50 mg/mL) was compared with or
without addition of heparin sulfate (100 U/mL) to the binding
medium. (B) Rosetting rate for three UpsA parasite variants with
and without heparin sulfate (100 U/mL) was determined by live
staining of parasite cultures with ethidium bromide (10 mg/mL)
followed by fluorescent microscopy. The rosetting rate was
calculated as the percentage of fluorescent infected erythrocytes
bound to 2 or more non-fluorescent uninfected erythrocytes. (C)
Comparison of median infected erythrocyte binding to triplicate
spots of immobilized CD36 protein (50 mg/mL) with or without
addition of heparin sulfate.
(TIF)
Figure S3 CD36 and ICAM-1 binding in the presence of
sulfated glycoconjugates. Infected erythrocyte binding was deter-
mined for two parasite lines (ItG-ICAM/ITvar16 and A4ultra/
ITvar14) without or in the presence of either 100 U/mL heparin
sulfate or 10 mg/mL dextran sulfate. (A) Infected erythrocyte
binding to CHO745 cells and CHO745 cell transfectants
expressing either human CD36 or ICAM-1 receptor protein. (B)
Infected erythrocyte binding to recombinant CD36-Fc or ICAM-
1-Fc fusion proteins at 50 mg/mL and to 2% bovine serum
albumin employed as a blocking agent. All proteins were
immobilized in 10 mL spots onto polystyrene substrate prior to
IE binding analysis.
(TIF)
Figure S4 Trypsin-resistant infected erythrocyte binding to
recombinant ICAM-1 protein. The IT4var31-expressing parasite
line P5B6 was either pretreated with 1 mg/mL trypsin or
untreated and then tested for binding to immobilized ICAM-1
protein at 50 mg/mL (A) or to immobilized CD36 protein at
50 mg/mL (B). P5B6-infected erythrocytes displayed trypsin-
resistant binding to ICAM-1. Binding could be blocked with a
monoclonal antibody to ICAM-1 (mAb 15.2), but not an isotype
control antibody.
(TIF)
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